1. Home
  2. CAC vs ZVRA Comparison

CAC vs ZVRA Comparison

Compare CAC & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Camden National Corporation

CAC

Camden National Corporation

HOLD

Current Price

$54.14

Market Cap

923.2M

Sector

Finance

ML Signal

HOLD

Logo Zevra Therapeutics Inc.

ZVRA

Zevra Therapeutics Inc.

HOLD

Current Price

$14.45

Market Cap

741.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAC
ZVRA
Founded
1875
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
923.2M
741.9M
IPO Year
1996
2015

Fundamental Metrics

Financial Performance
Metric
CAC
ZVRA
Price
$54.14
$14.45
Analyst Decision
Buy
Strong Buy
Analyst Count
2
5
Target Price
$47.00
$23.00
AVG Volume (30 Days)
107.2K
1.7M
Earning Date
04-28-2026
05-06-2026
Dividend Yield
3.51%
N/A
EPS Growth
6.08
159.21
EPS
1.29
0.60
Revenue
$41,739,000.00
$106,470,000.00
Revenue This Year
$19.15
$37.27
Revenue Next Year
$6.05
$53.42
P/E Ratio
$41.81
$23.60
Revenue Growth
16.96
350.91
52 Week Low
$35.00
$7.16
52 Week High
$56.23
$14.58

Technical Indicators

Market Signals
Indicator
CAC
ZVRA
Relative Strength Index (RSI) 53.81 70.27
Support Level $46.61 $8.26
Resistance Level $53.64 N/A
Average True Range (ATR) 1.62 0.58
MACD -0.03 0.06
Stochastic Oscillator 56.37 98.46

Price Performance

Historical Comparison
CAC
ZVRA

About CAC Camden National Corporation

Camden National Corporation is a banking solutions provider in the United States. Its core business is providing commercial banking products to individuals and corporates. Its consumer and commercial banking services entail services such as loans and deposits, savings and online banking, treasury management solutions and non-profit products to consumer, institutional, municipal, non-profit and commercial customers. The company also offers investment management and fiduciary services.

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.

Share on Social Networks: